Early Identification of Age-related Hearing Impairment
Launched by AALTO UNIVERSITY · May 13, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how we can better identify age-related hearing loss, which is a growing concern as many people age. The World Health Organization estimates that by 2050, 2.5 billion people will experience some level of hearing loss, with many needing help to improve their hearing. The goal of this study is to see if involving patients more actively in their hearing assessments can speed up the diagnosis process, helping more people get the support they need sooner.
To participate in this trial, individuals aged 65 to 74 who can understand Finnish or Swedish may be eligible, as long as they do not already have a clinical diagnosis of hearing loss. Those who join the study can expect to take part in assessments that aim to improve how we detect hearing issues related to aging. This is an important step in addressing the rising need for hearing rehabilitation in our communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Must be able to understand Finnish or Swedish
- Exclusion Criteria:
- • • Clinical diagnosis of hearing loss
Trial Officials
Jouni Partanen, Prof.
Principal Investigator
Aalto University
About Aalto University
Aalto University is a leading Finnish institution renowned for its interdisciplinary approach to research and education, particularly in science, technology, art, and business. With a strong emphasis on innovation and collaboration, Aalto University is committed to advancing knowledge and addressing complex societal challenges through cutting-edge clinical trials. The university fosters a vibrant research environment, facilitating partnerships with industry and healthcare sectors to translate scientific discoveries into practical applications. Aalto University’s expertise in research methodologies and commitment to ethical standards make it a trusted sponsor in the realm of clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Espoo, , Finland
Helsinki, , Finland
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0